Cancer drug tames atherosclerosis inflammation and plaque in animal models
A new Yale study has identified a promising therapeutic avenue for atherosclerosis, a condition caused by inflammation and plaque buildup in arteries. Martin Schwartz, Ph.D., Robert W. Berliner Professor of Medicine (Cardiology) and the study's principal investigator, investigates how the mechanical
<p>A new Yale study has identified a promising therapeutic avenue for atherosclerosis, a condition caused by inflammation and plaque buildup in arteries. Martin Schwartz, Ph.D., Robert W. Berliner Professor of Medicine (Cardiology) and the study's principal investigator, investigates how the mechanical</p>